About Lunaphore
Lunaphore is a company based in Morges (Switzerland) founded in 2014 by Deborah Heintze, Ata Tuna Ciftlik, and Diego G Dupouy was acquired by Bio-Techne in June 2023. Lunaphore has raised $82.74 million across 8 funding rounds from investors including Zurcher Kantonalbank, Bio-Techne and PHC Holdings. Lunaphore operates in a competitive market with competitors including Parallel Fluidics, CellFE, Sarcura, Lightcast Discovery and Hummingbird Nano, among others.
- Headquarter Morges, Switzerland
- Founders Deborah Heintze, Ata Tuna Ciftlik, Diego G Dupouy
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$82.74 M (USD)
in 8 rounds
-
Latest Funding Round
$10.8 M (USD), Debt – Venture
Mar 23, 2023
-
Investors
Zurcher Kantonalbank
& 8 more
-
Employee Count
Not available
-
Acquired by
Bio-Techne
(Jun 22, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Lunaphore
Unlock access to complete
Software Development Team
92 people
Sales and Marketing
76 people
Leadership Team
40 people
Product Management Team
35 people
Senior Team
31 people
Finance and Accounting
20 people
Human Resources and Administration
18 people
Advanced Team
13 people
Unlock access to complete
Funding Insights of Lunaphore
Lunaphore has successfully raised a total of $82.74M across 8 strategic funding rounds. The most recent funding activity was a Debt – Venture round of $10.8 million completed in March 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Lunaphore
Lunaphore has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include Zurcher Kantonalbank, Bio-Techne and PHC Holdings.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are provided to deep-tech startups.
|
Locked | Locked | Locked | |
|
Early-stage investments are directed toward ICT and health tech startups.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Lunaphore
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Lunaphore
Investment portfolio details for Lunaphore
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Lunaphore
Detailed financials for Lunaphore
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Lunaphore Comparisons
Peer comparison for Lunaphore
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Lunaphore
Lunaphore operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Parallel Fluidics, CellFE, Sarcura, Lightcast Discovery and Hummingbird Nano, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Microfluidic chips are provided for research labs using embossing technology.
|
|
| Locked | Locked | Locked |
Intracellular gene delivery platform is developed using microfluidic devices.
|
|
| Locked | Locked | Locked |
Cell therapy solutions for multiple therapeutic areas are developed.
|
|
| Locked | Locked | Locked |
Advanced single-cell analysis solutions are provided for biotechnology research.
|
|
| Locked | Locked | Locked |
Manufacturer of microfluidic chips
|
Detailed competitors of Lunaphore
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Lunaphore
Complete news archive for Lunaphore
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lunaphore
Lunaphore was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Lunaphore is headquartered in Morges, Switzerland. It is registered at Morges, Vaud, Switzerland.
Ata Tuna Ciftlik is the current CEO of Lunaphore. They have also founded this company.
Lunaphore is a funded company, having raised a total of $82.74M across 8 funding rounds to date.
Developer of microfluidic-based instruments for tumor analysis. The products include LabSat a tumor tissue staining device and COMET an automated staining and imaging platform that performs sequential immunofluorescence. The instruments are based on microfluidic staining technology called Fast Fluidic Exchange (FFEx).
Lunaphore's top competitors include CellFE, Parallel Fluidics and Lightcast Discovery.
Lunaphore has 9 investors. Key investors include Zurcher Kantonalbank, Bio-Techne, PHC Holdings, Ernst Göhner Stiftung, and Swiss Entrepreneurs Foundation.